M. Mazza, A. De Risio, C. Tozzini, R. Roncone, M. Casacchia - Vol. 8, June 2002, Issue 2
Testo Immagini Bibliografia Summary Indice
Studio naturalistico in pazienti
depressi trattati con farmaci serotoninergici e noradrenergici:
valutazione clinica e cognitiva a sei mesi
A naturalistic study of patients treated
with serotonergic and noradrenergic drugs:
clinical and cognitive assessment at a 6-month follow-up
1 Dencker SJ. The need for new and better antidepressssant: reboxetine
a new option. Acta Psichiatr Scand 2000;101(Suppl.402):6-11.
2 Christensen NJ, Vestegaard P, Sorensen T, Rafaelsen OJ. Cerebrospinal fluid adrenaline and noradrenaline in depressed patients. Acta Psichatr Scand 1980;61:178-82.
3 Winokur A. Thyroid axis and depressive disorders. In: Mann JJ, Kupfer DJ, eds. Biology of depressive disorders (part A). A sistem perpsective. New York: Plenum Press 1993:155-70.
4 Anisman H, Zacharko RM. Multiple neurochemical and behavioural consequences of stressors. Implications for depression. Pharmacol Ther 1990;46:119-36.
5 Dubini A, Bosc M, Polin V. Do noradrenaline and serotonin differentially affect social motivation and behaviour? Eur Neuropsychofarmacol 1997;1:49-55.
6 Frith CD. The Cognitive Neuropsychology of Schizophrenia. Lawrence Erlbaum Associates: Hove 1992.
7 Premack D, Woodruff G. Does the chimpanzee have a theory of mind? Behav Brain Sci 1978;4:515-26.
8 Mazza M, De Risio A, Surian L, Roncone R, Casacchia M. Selective impairments of Theory of Mind in people with schizophrenia. Schizophr Res 2001;47:299-308.
9 Phasler H. Attention. Cambridge: Cambrige University Press 1998.
10 Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
11 Beck AT, Ward CH, Mendelson M. An inventory for misuring depression. Arch Gen Psychiatry 1961;4:53-63.
12 Raven JC. Progressive Matrici Colore 1938. 0.S. Organizzazioni Speciali Firenze 1984.
13 Stablum F, Leonardi G, Mazzoldi M, Umiltà CA, Morra S. Attention and control deficits following closed head injury. Cortex 1994;29:603-18.
14 Happè F. An advanced test of theory of mind: understanding of story characters’ thoughts and feelings by able autistics, mentally handicapped and normal children and adults. J Autism Dev Dis 1994;24:129-54.
15 Frith CD, Corcoran R. Exploring «theory of mind» in people with schizophrenia. Psychol Med 1996.
16 Baron-Cohen S, Leslie A, Frith U. Does the autistic children have a ‘Theory of Mind’? Cognition 1985;21:37-46.
17 Happè F, Frith U. Theory of mind in autism. In: Schopler E, Mesibov G, eds. Learning and Cognition in Autism. New York: Plenum Press 1994.
18 Svensson TH. Brain noradrenaline and the mechanisms of action of antidepressant drugs. Acta Psychiatr Scand 2000:101(Suppl. 402):18-27.
19 Lacroix D, Blier P, Curet O, de Montigny C. Effects of long-term desipramine administration on noradrenergic neurotrasmission: electrophysiological studies in the rat brain. J Pharmacol Exp Ther 1991;257:1081-90.
20 Shallice T. Specific impairments of planning. London: Phil Trans Royal Society 1982.
21 Tanda G, Frau R, Di Chiara G. Chronic desipramine and fluoxetine differentially affect extracellular dopamine in the rat prefrontal cortex. Psychopharmacology 1996;127:83-7.
22 Thierry AM, Pirot S, Gioanni Y, Glowinski J. Dopamine function in the prefrontal cortex. In: Goldstein DS, Eisenhofer G, McCarty R, eds. Catecholamines, bridging basic science with clinical medicine: advances in pharmacology. San Diego: Academic Press 1997:717-20.